MedTrace Logo

Simultaneously PET/MRI in Prolonged DOC Patients

NCT04164680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2022-07-08

No results posted yet for this study

Summary

Recently introduced hybrid PET/MR scanners provide the opportunity to measure simultaneously, and in direct spatial correspondence, both metabolic demand and functional activity of the brain, hence capturing complementary information on the brain's physiological state. Here we exploited PET/MR simultaneous imaging to explore the relationship between the metabolic information provided by resting-state fluorodeoxyglucose-PET (FDG-PET) and fMRI (rs-fMRI) in patients with disorders of consciousness.

Conditions

  • Disorder of Consciousness
  • Minimally Conscious State
  • FDG-PET
  • Rs-fMRI

Interventions

DIAGNOSTIC_TEST

Multimodal Neuroimaging

fludeoxyglucose (FDG-)PET/MR imaging

Sponsors & Collaborators

  • Hangzhou Normal University

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04164680 on ClinicalTrials.gov